EMILY KREKE: Open Payments
NPI 1679079966 · EFFINGHAM, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$365 in 18 payments from 9 companies in 2025. Trend: 2023 $423 · 2024 $236 · 2025 $365
Food & beverage: $365
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 6 | $124 |
| Sage Therapeutics, LLC | 4 | $90 |
| Supernus Pharmaceuticals, Inc. | 2 | $41 |
| Boston Scientific Corporation | 1 | $22 |
| Exact Sciences Corporation | 1 | $21 |
| Organon LLC | 1 | $19 |
| Lilly USA, LLC | 1 | $17 |
| Astellas Pharma US Inc | 1 | $17 |
| Exeltis, USA Inc. | 1 | $15 |
Products named: GEMTESA, ZURZUVAE, Qelbree, Bulkamid, Cologuard Collection Kit, NEXPLANON, ZEPBOUND, Veozah.
Industry payments across IL — which companies pay providers there.
